–
El Corte Inglés has delivered to the Spanish Association Against Cancer (AECC) a check for the value of 197,275 euros for the research project on personalized immunotherapy. This amount comes from the proceeds of the campaign against breast cancer that El Corte Inglés organized last fall, on the occasion of the World Day Against Breast Cancer that is celebrated every October 19.
This new study is part of the agreement that the company has recently signed with the AECC, by which it undertakes to contribute one million euros in 5 years.
The research will focus on personalized immunotherapy and has an estimated duration of three years with two more of extension. The project will be carried out by a multidisciplinary team from the Hospital Clinic of Barcelona, Doce de Octubre (Madrid), Vall d’Hebron (Barcelona) and the University of Navarra, under the direction of Dr. Aleix Prat.
This new study, led by the doctor specializing in cancer medicine Aleix Prat, consists of activating the patients’ own immune system.
There are numerous approaches to activate it, from drugs to a more personalized treatment called Adoptive Cell Therapy or ACT. It is a type of immunotherapy that in its most general form consists of isolating the cells of the patient’s immune system and manipulating them in the laboratory and then returning them to the patient through a transfusion to attack the cancer.
The presentation of this check, which will be used to finance the research project, was attended by, among others, Ramón Reyes, president of the Spanish Association Against Cancer (AECC), and the Director of Communication of El Corte Inglés, Ester Uriol.
El Corte Inglés has been in close collaboration with the Spanish Association Against Cancer (AECC) for years, and the result of this is the joint project they develop against breast cancer. It is an initiative that has evolved very positively and that has allowed the company to fund three research projects in their entirety so far.
– .
